DeeptiASinghMD

PubMed

• 22 citations
  Alternative cereals can improve water use and nutrient supply in India
  Kyle Frankel Davis, Davide Danilo Chiarelli, Maria Cristina Rulli, Ashwini Chhatre, Brian Richter, Deepti Singh, Ruth DeFries> ;Science Advances. 2018 Jul 1
• 4 citations
  The epothilone B analogue ixabepilone in patients with advanced hepatobiliary cancers: a trial of the University of Chicago Phase II Consortium
  Halla Sayed Nimeiri, D. A. Singh, Kristen Kasza, David A. Taber, Rafat Ansari, Everett E. Vokes, Hedy L. Kindler> ;Investigational New Drugs. 2010 Dec 1
• 212 citations
  A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer
  Ramesh K. Ramanathan, Chandra P. Belani, D. A. Singh, Michael Tanaka, Heinz-Josef Lenz, Yun Yen, Hedy L. Kindler, Syma Iqbal, Jeff Longmate, Philip C. Mack, Georg Lurj...> ;Cancer Chemotherapy and Pharmacology. 2009 Jan 24
• 25 citations
  A phase I and pharmacokinetic study of the quinoxaline antitumour Agent R(+)XK469 in patients with advanced solid tumours.
  Samir D. Undevia, Federico Innocenti, Jacqueline Ramírez, Larry House, Apurva A. Desai, Linda A. Skoog, D. A. Singh, Theodore Karrison, Hedy L. Kindler, Mark J. Ratain> ;European Journal of Cancer. 2008 Aug 1
• 71 citations
  Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer
  Howard L. Kaufman, Heinz-Josef Lenz, John L. Marshall, D. A. Singh, Chris Garett, Christine Cripps, Malcolm J. Moore, Margaret von Mehren, Richard Dalfen, William J. H...> ;Clinical Cancer Research. 2008 Aug 1
• 48 citations
  Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study.
  Heinz Joseph Lenz, F. C. Lee, Daniel G. Haller, D. A. Singh, Al B. Benson, Dirk Strumberg, Ronald Yanagihara, James C. Yao, Alexandra T. Phan, Jaffer A. Ajani> ;Cancer. 2007 Jan 1
• 247 citations
  A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas.
  Ignacio Duran, J. Kortmansky, D. Singh, H. Hirte, Walter Kocha, Glenwood D. Goss, Lisa W. Le, Amit M. Oza, Trudey Nicklee, James Ho, Diana C. Birle, Gregory R. Pond, A...> ;British Journal of Cancer. 2006 Nov 6
• A phase II trial of the epothilone B analog BMS-247550 in patients (pts) with hepatobiliary cancer (HBC): An updated analysis.
  Singh DA, Taber D, Ansari R, Lenz HJ, Agamah E, Nattam S, Wade-Oliver K, Kasza K, Vokes EE, Kindler HL> ;J. Clin. Oncol.. 2006-06-20
• 78 citations
  Multicenter Phase II Trial of S-1 Plus Cisplatin in Patients With Untreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
  J. A. Ajani, F. C. Lee, D. A. Singh, D. G. Haller, Heinz-Josef Lenz, Al B. Benson, Ronald Yanagihara, Alexandria T. Phan, James C. Yao, Dirk Strumberg> ;Journal of Clinical Oncology. 2006 Feb 1
• 362 citations
  Phase II Trial of Bevacizumab Plus Gemcitabine in Patients With Advanced Pancreatic Cancer
  Hedy L. Kindler, Gregory Friberg, D. A. Singh, Gershon Y. Locker, Sreenivasa Nattam, Mark Kozloff, David A. Taber, Theodore Karrison, Abraham H. Dachman, Walter M. Sta...> ;Journal of Clinical Oncology. 2005 Nov 1
• A phase II trial of temsirolimus in metastatic neuroendocrine carcinomas (NECs).
  Duran I, Le L, Saltman D, Kortmansky J, Kocha W, Singh D, Pond GR, Peralba JM, Dancey J, Siu LL> ;J. Clin. Oncol.. 2005-06-01
• Multi-center phase II study of S-1 plus cisplatin in patients with advanced gastric carcinoma (AGC).
  Ajani JA, Phan A, Yao JC, Lee F, Singh DA, Haller D, Benson AB, Lenz H, Yanagihara RH, Strumberg D> ;J. Clin. Oncol.. 2005-06-01
• Join now to see all